Trexquant Investment LP

Position in VCYT — Veracyte, Inc.

CIK 1633445 STAMFORD, CT

Position in VCYT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,192,421

+$3,861,558 QoQ

Shares Held

130,159

+1556.2% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $87,777,569 across 14 Diagnostics & Research names. VCYT ranks #8 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	130,479	$26,094,495
2	MEDP	Medpace Holdings, Inc.	28,516	$13,693,098
3	TWST	Twist Bioscience Corp	170,107	$8,083,484
4	GH	Guardant Health, Inc.	85,901	$7,934,675
5	DHR	Danaher Corp /De/	39,489	$7,487,114
6	ICLR	Icon PLC	62,628	$6,930,414
7	WGS	GeneDx Holdings Corp.	77,350	$4,967,417
8	VCYT	Veracyte, Inc. This page	130,159	$4,192,421

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,192,421	130,159	+1556.2%	Shares	Sole	2026-05-15
2025-12-31	$330,863	7,859	-89.5%	Shares	Sole	2026-02-17
2025-06-30	$2,018,897	74,691	-60.4%	Shares	Sole	2025-08-12
2025-03-31	$5,588,817	188,493	-5.4%	Shares	Sole	2025-05-14
2024-12-31	$7,891,606	199,283	-1.9%	Shares	Sole	2025-02-12
2024-09-30	$6,913,353	203,095	+527.6%	Shares	Sole	2024-11-12
2023-12-31	$890,306	32,363	-69.5%	Shares	Sole	2024-02-09
2023-09-30	$2,370,575	106,161	+87.5%	Shares	Sole	2023-11-13
2023-06-30	$1,442,085	56,619	-56.0%	Shares	Sole	2023-08-11
2023-03-31	$2,867,936	128,607	+32.9%	Shares	Sole	2023-05-15
2022-12-31	$2,296,399	96,772	+59.3%	Shares	Sole	2023-02-13
2022-09-30	$1,008,483	60,752	+242.1%	Shares	Sole	2022-11-14
2020-12-31	$869,174	17,760	+47.5%	Shares	Sole	2021-02-11
2020-09-30	$391,147	12,039	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.